The authors go on to suggest that since PD pathology is hypothesized to start in the enteric nervous system, this poses an important need to assess klotho in the gastrointestinal tract of people with PD and evaluate whether modulation of klotho in the gut may serve as a disease-modifying strategy. Here, KL is linked to Parkinson disease.